AbbVie (ABBV)
(Delayed Data from NYSE)
$158.26 USD
-1.35 (-0.85%)
Updated May 23, 2024 04:00 PM ET
After-Market: $158.29 +0.03 (0.02%) 4:42 PM ET
3-Hold of 5 3
B Value C Growth C Momentum B VGM
Brokerage Reports
AbbVie Inc. [ABBV]
Reports for Purchase
Showing records 361 - 376 ( 376 total )
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended April 3
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended March 28
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended March 6
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Technicals Prescribe Long Positions in Health Care Stocks
Provider: Drexel Hamilton, LLC
Analyst: SINE B